Accepted Manuscript Title: Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab Authors: Martin ˇ Spaˇ cek, Petra Obrtl´ ıkov´ a, Stanislava Hrobkov´ a, Eduard Cmunt, Josef Karban, Jan Molinsk ´ y, Martin ˇ Simkoviˇ c, Heidi Mocikov´ a, Lekaa Mohammadov´ a, Anna Panovsk´ a, Jan Nov´ ak, Marek Trnˇ en´ y, Luk´ aˇ s Smolej, Michael Doubek PII: S0145-2126(19)30028-1 DOI: https://doi.org/10.1016/j.leukres.2019.02.002 Reference: LR 6115 To appear in: Leukemia Research Received date: 17 December 2018 Revised date: 8 February 2019 Accepted date: 10 February 2019 Please cite this article as: ˇ Spaˇ cek M, Obrtl´ ıkov´ a P, Hrobkov´ a S, Cmunt E, Karban J, Molinsk´ y J, ˇ Simkoviˇ c M, Mocikov´ a H, Mohammadov´ a L, Panovsk´ a A, Nov´ ak J, Trnˇ en´ y M, Smolej L, Doubek M, Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab, Leukemia Research (2019), https://doi.org/10.1016/j.leukres.2019.02.002 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.